(Q34547781)

2 August 2017

1 reference

title

Yellow fever: an update (English)

1 reference

2 August 2017

0 references

1 reference

T P Monath

1 reference

2 August 2017

publication date

1 August 2001

1 reference

Lancet Infectious Diseases

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

11-20

1 reference

Population dynamics of flaviviruses revealed by molecular phylogenies

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Yellow fever: a decade of reemergence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Flavivirus genome organization, expression, and replication

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Differing infection patterns of dengue and yellow fever viruses in a human hepatoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Yellow fever vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Anaphylaxis from yellow fever vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Yellow fever vaccination and pregnancy: a four-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Exposure to yellow fever vaccine in early pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Does Restricted Distribution Limit Access and Coverage of Yellow Fever Vaccine in the United States?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

Urbanisation of yellow fever in Santa Cruz, Bolivia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900016-0

7 January 2021

10.1016/S1473-3099(01)00016-0

Identifiers

DOI

1 reference

2 August 2017

1 reference